Advanced Search:
Equity Index

FAGR.BR - FAGRON

€18.74  0 (0%)

Updated: 08:06 May 9, 2024 EST

Next Session's AI Forecast

98.95%

Avg. Accuracy (AI)

€18.4

Next Week's AI Forecast

83.33%

Trend's Accuracy (AI)

€18.96

FAGRON's Position Within the Drug Manufacturers—Specialty & Generic Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

FAGRON - HISTORICAL DATA 6M

  • Last price

    €18.74

  • Daily change

    €0

  • Previous Close

    €18.74

  • Last Updated

    08:06 May 9, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.63 0.51 0.16 0.08 0.06

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
1.01 0.96 0.89 0.84 0.91

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 100% 100% 100%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
18.45 2.05% 18.08 2.61% 17.62 2.09% 17.26

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
2.4 20 2.2 70.59

FAGRON Technical Analysis News

FAGRON

Venecoweg 20A
Nazareth 9810
Belgium
32 8 001 28 80
https://www.fagron.com

Sectors: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
F. Time Employees: 3282
Description

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Corporate Governance

Fagron NV’s ISS Governance QualityScore as of May 1, 2024 is 4. The pillar scores are Audit: 9; Board: 6; Shareholder Rights: 4; Compensation: 3.